Financhill
Back

Phathom Pharmaceuticals Vs. Oramed Pharmaceuticals Industry Stock Comparison

Buy
69

PHAT
Phathom Pharmaceuticals

Last Price:
$10.65
Seasonality Move:
13.25%
Sell
19

ORMP
Oramed Pharmaceuticals

Last Price:
$2.17
Seasonality Move:
0.24%
Buy
69
Phathom Pharmaceuticals (PHAT) is a Buy

Is Phathom Pharmaceuticals a Buy, Sell or Hold?

  • The current Phathom Pharmaceuticals [PHAT] share price is $10.64. The Score for PHAT is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Oramed Pharmaceuticals (ORMP) is a Sell

Is Oramed Pharmaceuticals a Buy, Sell or Hold?

  • The current Oramed Pharmaceuticals [ORMP] share price is $2.12. The Score for ORMP is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • ORMP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PHAT Stock Price Chart

What is Phathom Pharmaceuticals's stock price today?

  • The Phathom Pharmaceuticals share price today is $10.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORMP Stock Price Chart

What is Oramed Pharmaceuticals's stock price today?

  • The Oramed Pharmaceuticals share price today is $2.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing slight buying pressure.

PHAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.54 Buy
Relative Strength Index (14 RSI): 86.4 Buy
Chaikin Money Flow: 532694 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ORMP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 41.73 Sell
Chaikin Money Flow: -42954 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

PHAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.23 Buy
20-day SMA: 5.86 Buy
50-day SMA: 4.65 Buy
200-day SMA: 9.2 Buy
8-day EMA: 8.53 Buy
20-day EMA: 6.6 Buy
50-day EMA: 5.48 Buy
200-day EMA: 7.49 Buy

ORMP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.21 Sell
20-day SMA: 2.2 Sell
50-day SMA: 2.22 Sell
200-day SMA: 2.32 Sell
8-day EMA: 2.21 Sell
20-day EMA: 2.22 Sell
50-day EMA: 2.23 Sell
200-day EMA: 2.33 Sell

Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.92 per share, an increase next quarter of $0.37 per share, an increase this year of $1.80 per share, and an increase next year of $2.44 per share.

Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.

Phathom Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oramed Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):